array(40) {
  [0]=>
  string(4) "4163"
  ["article_id"]=>
  string(4) "4163"
  [1]=>
  string(53) "5th International Congress on Epigenetics & Chromatin"
  ["article_title"]=>
  string(53) "5th International Congress on Epigenetics & Chromatin"
  [2]=>
  string(150) "Epigenetics Conference, The world's largest Epigenetics Conference and Gathering for the Research Community.Join the&am"
  ["short_description"]=>
  string(150) "Epigenetics Conference, The world's largest Epigenetics Conference and Gathering for the Research Community.Join the&am"
  [3]=>
  string(576) "Epigenetics Conference, The world's largest Epigenetics Conference and Gathering for the Research Community.Join the 5th International Congress on Epigenetics & Chromatin at Vienna, Austria during August 22-23, 2019&#nlTheme: Epigenetics: Global leading changes to advance Diagnosis & Precision medicineCancer, Cardio, Reproductive, Diabetes, Surgery, Neuroscience, Healthcare, Pathology, Radiology&#nlEpigenetics 2019 invites all the p…"
  ["description"]=>
  string(576) "Epigenetics Conference, The world's largest Epigenetics Conference and Gathering for the Research Community.Join the 5th International Congress on Epigenetics & Chromatin at Vienna, Austria during August 22-23, 2019&#nlTheme: Epigenetics: Global leading changes to advance Diagnosis & Precision medicineCancer, Cardio, Reproductive, Diabetes, Surgery, Neuroscience, Healthcare, Pathology, Radiology&#nlEpigenetics 2019 invites all the p…"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(100) "
https://www.pharmiweb.com/event/5th-international-congress-on-epigenetics-chromatin                "
  ["blog_url"]=>
  string(100) "
https://www.pharmiweb.com/event/5th-international-congress-on-epigenetics-chromatin                "
  [15]=>
  string(19) "1970-01-01 07:30:00"
  ["add_date"]=>
  string(19) "1970-01-01 07:30:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-08-14 10:55:46"
  ["create_at"]=>
  string(19) "2019-08-14 10:55:46"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "4164"
  ["article_id"]=>
  string(4) "4164"
  [1]=>
  string(64) "World Congress on Advanced Structural and Molecular Biology 2018"
  ["article_title"]=>
  string(64) "World Congress on Advanced Structural and Molecular Biology 2018"
  [2]=>
  string(150) "Pulsus Group is an intentionally renowned per reviewed publisher in scientific, technical, and medical journals established"
  ["short_description"]=>
  string(150) "Pulsus Group is an intentionally renowned per reviewed publisher in scientific, technical, and medical journals established"
  [3]=>
  string(552) "Pulsus Group is an intentionally renowned per reviewed publisher in scientific, technical, and medical journals established in the year 1984 with offices in Ontario, Canada, and Hyderabad, India has acquired Andrew John Publishing and open access journals to expand its Open Access Publishing through its 50+ journals in association with 20+ International medical and scientific societies.&#nl&#nlPULSUS takes a immense pleasure in inviting all the participan…"
  ["description"]=>
  string(552) "Pulsus Group is an intentionally renowned per reviewed publisher in scientific, technical, and medical journals established in the year 1984 with offices in Ontario, Canada, and Hyderabad, India has acquired Andrew John Publishing and open access journals to expand its Open Access Publishing through its 50+ journals in association with 20+ International medical and scientific societies.&#nl&#nlPULSUS takes a immense pleasure in inviting all the participan…"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(113) "
https://www.pharmiweb.com/event/world-congress-on-advanced-structural-and-molecular-biology-2018                "
  ["blog_url"]=>
  string(113) "
https://www.pharmiweb.com/event/world-congress-on-advanced-structural-and-molecular-biology-2018                "
  [15]=>
  string(19) "1970-01-01 07:30:00"
  ["add_date"]=>
  string(19) "1970-01-01 07:30:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-08-14 10:55:46"
  ["create_at"]=>
  string(19) "2019-08-14 10:55:46"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "4165"
  ["article_id"]=>
  string(4) "4165"
  [1]=>
  string(52) "Global Conference on Addiction and Behavioral Health"
  ["article_title"]=>
  string(52) "Global Conference on Addiction and Behavioral Health"
  [2]=>
  string(150) "Magnus Group is delighted to invite you to the Global Conference on Addiction and Behavioral Health scheduled on August 22-24, 2019 in London, UK with"
  ["short_description"]=>
  string(150) "Magnus Group is delighted to invite you to the Global Conference on Addiction and Behavioral Health scheduled on August 22-24, 2019 in London, UK with"
  [3]=>
  string(528) "Magnus Group is delighted to invite you to the Global Conference on Addiction and Behavioral Health scheduled on August 22-24, 2019 in London, UK with a root motif “Unifying the new discoveries and advanced approaches towards Addiction” which is cornerstone for accomplishing Addiction Rehabilitation and Psychiatry problems. Addiction therapy will extend an opportunity for all marketing societies working on addiction and comorbid psychiatric disorders to exhibit their work.&#nl&#nlAddiction Conferenc…"
  ["description"]=>
  string(528) "Magnus Group is delighted to invite you to the Global Conference on Addiction and Behavioral Health scheduled on August 22-24, 2019 in London, UK with a root motif “Unifying the new discoveries and advanced approaches towards Addiction” which is cornerstone for accomplishing Addiction Rehabilitation and Psychiatry problems. Addiction therapy will extend an opportunity for all marketing societies working on addiction and comorbid psychiatric disorders to exhibit their work.&#nl&#nlAddiction Conferenc…"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(101) "
https://www.pharmiweb.com/event/global-conference-on-addiction-and-behavioral-health                "
  ["blog_url"]=>
  string(101) "
https://www.pharmiweb.com/event/global-conference-on-addiction-and-behavioral-health                "
  [15]=>
  string(19) "1970-01-01 07:30:00"
  ["add_date"]=>
  string(19) "1970-01-01 07:30:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-08-14 10:55:46"
  ["create_at"]=>
  string(19) "2019-08-14 10:55:46"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "4166"
  ["article_id"]=>
  string(4) "4166"
  [1]=>
  string(78) "7th Edition of World Congress on  Cancer Research, Survivorship and Management"
  ["article_title"]=>
  string(78) "7th Edition of World Congress on  Cancer Research, Survivorship and Management"
  [2]=>
  string(150) "The thoughts which you are working or looking on may require some extraordinary procedures for the finish. In this way, this meeting gives a stage to "
  ["short_description"]=>
  string(150) "The thoughts which you are working or looking on may require some extraordinary procedures for the finish. In this way, this meeting gives a stage to "
  [3]=>
  string(512) "The thoughts which you are working or looking on may require some extraordinary procedures for the finish. In this way, this meeting gives a stage to share thoughts as individuals over the globe will assemble at a similar place from various locales, nations, colleges. Individuals with the diverse thought are additionally welcome to demonstrate their work or exhibit the work and even they can impart the plan to the general population of various thoughts, can team up the work, and can examine with…"
  ["description"]=>
  string(512) "The thoughts which you are working or looking on may require some extraordinary procedures for the finish. In this way, this meeting gives a stage to share thoughts as individuals over the globe will assemble at a similar place from various locales, nations, colleges. Individuals with the diverse thought are additionally welcome to demonstrate their work or exhibit the work and even they can impart the plan to the general population of various thoughts, can team up the work, and can examine with…"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(125) "
https://www.pharmiweb.com/event/7th-edition-of-world-congress-on-cancer-research-survivorship-and-management                "
  ["blog_url"]=>
  string(125) "
https://www.pharmiweb.com/event/7th-edition-of-world-congress-on-cancer-research-survivorship-and-management                "
  [15]=>
  string(19) "1970-01-01 07:30:00"
  ["add_date"]=>
  string(19) "1970-01-01 07:30:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-08-14 10:55:46"
  ["create_at"]=>
  string(19) "2019-08-14 10:55:46"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "4167"
  ["article_id"]=>
  string(4) "4167"
  [1]=>
  string(69) "6TH INTERNATIONAL CONGRESS & EXPO ON BIOTECHNOLOGY AND NANOTECHNOLOGY"
  ["article_title"]=>
  string(69) "6TH INTERNATIONAL CONGRESS & EXPO ON BIOTECHNOLOGY AND NANOTECHNOLOGY"
  [2]=>
  string(150) "6th International Congress & Expo on Biotechnology and Nanotechnology (BioNanotech-2019), which will be held during August 22-23, 2019 at Barc"
  ["short_description"]=>
  string(150) "6th International Congress & Expo on Biotechnology and Nanotechnology (BioNanotech-2019), which will be held during August 22-23, 2019 at Barc"
  [3]=>
  string(523) "6th International Congress & Expo on Biotechnology and Nanotechnology (BioNanotech-2019), which will be held during August 22-23, 2019 at Barcelona, Spain is now an established event, attracting global participant’s intent on sharing, exchanging and exploring new avenues of Biotechnology and Nanotechnology and related research and latest developments. The event will have 5-6 world level (Highly cited class) plenary speakers, established Keynote speakers, active Invited speakers and fresh con…"
  ["description"]=>
  string(523) "6th International Congress & Expo on Biotechnology and Nanotechnology (BioNanotech-2019), which will be held during August 22-23, 2019 at Barcelona, Spain is now an established event, attracting global participant’s intent on sharing, exchanging and exploring new avenues of Biotechnology and Nanotechnology and related research and latest developments. The event will have 5-6 world level (Highly cited class) plenary speakers, established Keynote speakers, active Invited speakers and fresh con…"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(116) "
https://www.pharmiweb.com/event/6th-international-congress-expo-on-biotechnology-and-nanotechnology                "
  ["blog_url"]=>
  string(116) "
https://www.pharmiweb.com/event/6th-international-congress-expo-on-biotechnology-and-nanotechnology                "
  [15]=>
  string(19) "1970-01-01 07:30:00"
  ["add_date"]=>
  string(19) "1970-01-01 07:30:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-08-14 10:55:46"
  ["create_at"]=>
  string(19) "2019-08-14 10:55:46"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "4168"
  ["article_id"]=>
  string(4) "4168"
  [1]=>
  string(53) "29th International Congress on Vision science and Eye"
  ["article_title"]=>
  string(53) "29th International Congress on Vision science and Eye"
  [2]=>
  string(154) "Vision Science and Eye going to be held at August 22-23, 2019, Austria, Vienna. The Theme of the meeting is “VISION IS A PICTURE OF THE FUTURE THAT "
  ["short_description"]=>
  string(154) "Vision Science and Eye going to be held at August 22-23, 2019, Austria, Vienna. The Theme of the meeting is “VISION IS A PICTURE OF THE FUTURE THAT "
  [3]=>
  string(523) "Vision Science and Eye going to be held at August 22-23, 2019, Austria, Vienna. The Theme of the meeting is “VISION IS A PICTURE OF THE FUTURE THAT PRODUCES PASSION", which Vision Science 2019 will be honoured to welcome you to the 29th International Congress on focuses on the essentialness of vision and most recent innovative improvements in the field of Ophthalmology. Our meeting accumulates Ophthalmologists, Orthoptists, Researchers, Associate Professors, and Scholars from both scholastic and…"
  ["description"]=>
  string(523) "Vision Science and Eye going to be held at August 22-23, 2019, Austria, Vienna. The Theme of the meeting is “VISION IS A PICTURE OF THE FUTURE THAT PRODUCES PASSION", which Vision Science 2019 will be honoured to welcome you to the 29th International Congress on focuses on the essentialness of vision and most recent innovative improvements in the field of Ophthalmology. Our meeting accumulates Ophthalmologists, Orthoptists, Researchers, Associate Professors, and Scholars from both scholastic and…"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(102) "
https://www.pharmiweb.com/event/29th-international-congress-on-vision-science-and-eye                "
  ["blog_url"]=>
  string(102) "
https://www.pharmiweb.com/event/29th-international-congress-on-vision-science-and-eye                "
  [15]=>
  string(19) "1970-01-01 07:30:00"
  ["add_date"]=>
  string(19) "1970-01-01 07:30:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-08-14 10:55:46"
  ["create_at"]=>
  string(19) "2019-08-14 10:55:46"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "4169"
  ["article_id"]=>
  string(4) "4169"
  [1]=>
  string(62) "         7th World Congress on Earth and Environmental Science"
  ["article_title"]=>
  string(62) "         7th World Congress on Earth and Environmental Science"
  [2]=>
  string(150) "Earth Science is a global platform to discuss and learn about Ecology and its Environmental fields, Geosciences and Geology, Geophysics and A"
  ["short_description"]=>
  string(150) "Earth Science is a global platform to discuss and learn about Ecology and its Environmental fields, Geosciences and Geology, Geophysics and A"
  [3]=>
  string(312) "Earth Science is a global platform to discuss and learn about Ecology and its Environmental fields, Geosciences and Geology, Geophysics and Atmospheric Sciences, Climate Change and Extreme Weather, Global Warming and Environmental Change, Effect of Climate Change on Ecosystem, Environment and Pollution"
  ["description"]=>
  string(312) "Earth Science is a global platform to discuss and learn about Ecology and its Environmental fields, Geosciences and Geology, Geophysics and Atmospheric Sciences, Climate Change and Extreme Weather, Global Warming and Environmental Change, Effect of Climate Change on Ecosystem, Environment and Pollution"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(102) "
https://www.pharmiweb.com/event/7th-world-congress-on-earth-and-environmental-science                "
  ["blog_url"]=>
  string(102) "
https://www.pharmiweb.com/event/7th-world-congress-on-earth-and-environmental-science                "
  [15]=>
  string(19) "1970-01-01 07:30:00"
  ["add_date"]=>
  string(19) "1970-01-01 07:30:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-08-14 10:55:46"
  ["create_at"]=>
  string(19) "2019-08-14 10:55:46"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "4170"
  ["article_id"]=>
  string(4) "4170"
  [1]=>
  string(54) "Quality Control Laboratory Compliance - cGMPs and GLPs"
  ["article_title"]=>
  string(54) "Quality Control Laboratory Compliance - cGMPs and GLPs"
  [2]=>
  string(159) "Learning Objectives:&#nlKey goals of the conference will include learning:&#nl&#nlThe basics of FDA law and regulations governing QC laboratories responsible f"
  ["short_description"]=>
  string(159) "Learning Objectives:&#nlKey goals of the conference will include learning:&#nl&#nlThe basics of FDA law and regulations governing QC laboratories responsible f"
  [3]=>
  string(522) "Learning Objectives:&#nlKey goals of the conference will include learning:&#nl&#nlThe basics of FDA law and regulations governing QC laboratories responsible for testing research materials, components of FDA-regulated products, and finished FDA-regulated products (pharmaceuticals, biologics, medical devices, cosmetics, and foods).&#nlLaboratory organization, personnel qualification and training requirements.&#nlDocumentation and record-keeping requirements, including e-records and data integrity.&#nlSampl…"
  ["description"]=>
  string(522) "Learning Objectives:&#nlKey goals of the conference will include learning:&#nl&#nlThe basics of FDA law and regulations governing QC laboratories responsible for testing research materials, components of FDA-regulated products, and finished FDA-regulated products (pharmaceuticals, biologics, medical devices, cosmetics, and foods).&#nlLaboratory organization, personnel qualification and training requirements.&#nlDocumentation and record-keeping requirements, including e-records and data integrity.&#nlSampl…"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(101) "
https://www.pharmiweb.com/event/quality-control-laboratory-compliance-cgmps-and-glps                "
  ["blog_url"]=>
  string(101) "
https://www.pharmiweb.com/event/quality-control-laboratory-compliance-cgmps-and-glps                "
  [15]=>
  string(19) "1970-01-01 07:30:00"
  ["add_date"]=>
  string(19) "1970-01-01 07:30:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-08-14 10:55:46"
  ["create_at"]=>
  string(19) "2019-08-14 10:55:46"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "4371"
  ["article_id"]=>
  string(4) "4371"
  [1]=>
  string(89) "Celgene’s QUAZAR AML-001 trial of CC-486 meets primary and key secondary endpoints"
  ["article_title"]=>
  string(89) "Celgene’s QUAZAR AML-001 trial of CC-486 meets primary and key secondary endpoints"
  [2]=>
  string(150) "The study evaluated the efficacy and safety of investigational therapy CC-486 as maintenance therapy in patients with newly diagnosed acute myeloid le"
  ["short_description"]=>
  string(150) "The study evaluated the efficacy and safety of investigational therapy CC-486 as maintenance therapy in patients with newly diagnosed acute myeloid le"
  [3]=>
  string(642) "
The study evaluated the efficacy and safety of investigational therapy CC-486 as maintenance therapy in patients with newly diagnosed acute myeloid leukemia (AML) who achieved first complete response 
&#nl
The post Celgene’s QUAZAR AML-001 trial of CC-486 meets primary and key secondary endpoints appeared first on Pharmaceutical Business review.
&#nl"
  ["description"]=>
  string(642) "
The study evaluated the efficacy and safety of investigational therapy CC-486 as maintenance therapy in patients with newly diagnosed acute myeloid leukemia (AML) who achieved first complete response 
&#nl
The post Celgene’s QUAZAR AML-001 trial of CC-486 meets primary and key secondary endpoints appeared first on Pharmaceutical Business review.
&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "30"
  ["rss_id"]=>
  string(2) "30"
  [14]=>
  string(134) "https://www.pharmaceutical-business-review.com/news/celgenes-quazar-aml-001-trial-of-cc-486-meets-primary-and-key-secondary-endpoints/"
  ["blog_url"]=>
  string(134) "https://www.pharmaceutical-business-review.com/news/celgenes-quazar-aml-001-trial-of-cc-486-meets-primary-and-key-secondary-endpoints/"
  [15]=>
  string(19) "1970-01-01 07:30:00"
  ["add_date"]=>
  string(19) "1970-01-01 07:30:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-09-14 14:31:35"
  ["create_at"]=>
  string(19) "2019-09-14 14:31:35"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "4372"
  ["article_id"]=>
  string(4) "4372"
  [1]=>
  string(50) "Aytu BioScience to acquire Innovus Pharmaceuticals"
  ["article_title"]=>
  string(50) "Aytu BioScience to acquire Innovus Pharmaceuticals"
  [2]=>
  string(150) "This initial consideration to Innovus common shareholders is estimated to consist of approximately 4.2 million shares of Aytu stock. Additional consid"
  ["short_description"]=>
  string(150) "This initial consideration to Innovus common shareholders is estimated to consist of approximately 4.2 million shares of Aytu stock. Additional consid"
  [3]=>
  string(565) "
This initial consideration to Innovus common shareholders is estimated to consist of approximately 4.2 million shares of Aytu stock. Additional consideration for up to $16 million in milestone 
&#nl
The post Aytu BioScience to acquire Innovus Pharmaceuticals appeared first on Pharmaceutical Business review.
&#nl"
  ["description"]=>
  string(565) "
This initial consideration to Innovus common shareholders is estimated to consist of approximately 4.2 million shares of Aytu stock. Additional consideration for up to $16 million in milestone 
&#nl
The post Aytu BioScience to acquire Innovus Pharmaceuticals appeared first on Pharmaceutical Business review.
&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "30"
  ["rss_id"]=>
  string(2) "30"
  [14]=>
  string(103) "https://www.pharmaceutical-business-review.com/news/aytu-bioscience-to-acquire-innovus-pharmaceuticals/"
  ["blog_url"]=>
  string(103) "https://www.pharmaceutical-business-review.com/news/aytu-bioscience-to-acquire-innovus-pharmaceuticals/"
  [15]=>
  string(19) "1970-01-01 07:30:00"
  ["add_date"]=>
  string(19) "1970-01-01 07:30:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-09-14 14:31:35"
  ["create_at"]=>
  string(19) "2019-09-14 14:31:35"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "4373"
  ["article_id"]=>
  string(4) "4373"
  [1]=>
  string(83) "FDA approves GSK’s Nucala for young children with severe eosinophilic asthma"
  ["article_title"]=>
  string(83) "FDA approves GSK’s Nucala for young children with severe eosinophilic asthma"
  [2]=>
  string(153) "Nucala is claimed to be the only targeted biologic to secure approval for the condition in the six to 11-year age group in the US. The FDA approval &#nlT"
  ["short_description"]=>
  string(153) "Nucala is claimed to be the only targeted biologic to secure approval for the condition in the six to 11-year age group in the US. The FDA approval &#nlT"
  [3]=>
  string(524) "
Nucala is claimed to be the only targeted biologic to secure approval for the condition in the six to 11-year age group in the US. The FDA approval 
&#nl
The post FDA approves GSK’s Nucala for young children with severe eosinophilic asthma appeared first on Pharmaceutical Business review.
&#nl"
  ["description"]=>
  string(524) "
Nucala is claimed to be the only targeted biologic to secure approval for the condition in the six to 11-year age group in the US. The FDA approval 
&#nl
The post FDA approves GSK’s Nucala for young children with severe eosinophilic asthma appeared first on Pharmaceutical Business review.
&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "30"
  ["rss_id"]=>
  string(2) "30"
  [14]=>
  string(74) "https://www.pharmaceutical-business-review.com/news/fda-gsk-nucala-asthma/"
  ["blog_url"]=>
  string(74) "https://www.pharmaceutical-business-review.com/news/fda-gsk-nucala-asthma/"
  [15]=>
  string(19) "1970-01-01 07:30:00"
  ["add_date"]=>
  string(19) "1970-01-01 07:30:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-09-14 14:31:35"
  ["create_at"]=>
  string(19) "2019-09-14 14:31:35"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "4374"
  ["article_id"]=>
  string(4) "4374"
  [1]=>
  string(102) "VBI Vaccines announces phase 2a trial of VBI-1901 plus AS01B adjuvant system in recurrent glioblastoma"
  ["article_title"]=>
  string(102) "VBI Vaccines announces phase 2a trial of VBI-1901 plus AS01B adjuvant system in recurrent glioblastoma"
  [2]=>
  string(155) "As part of the collaboration, VBI plans to add an additional study arm to Part B of the company’s ongoing, multi-center, open-label Phase 1/2a clini"
  ["short_description"]=>
  string(155) "As part of the collaboration, VBI plans to add an additional study arm to Part B of the company’s ongoing, multi-center, open-label Phase 1/2a clini"
  [3]=>
  string(710) "
As part of the collaboration, VBI plans to add an additional study arm to Part B of the company’s ongoing, multi-center, open-label Phase 1/2a clinical study targeting recurrent 
&#nl
The post VBI Vaccines announces phase 2a trial of VBI-1901 plus AS01B adjuvant system in recurrent glioblastoma appeared first on Pharmaceutical Business review.
&#nl"
  ["description"]=>
  string(710) "
As part of the collaboration, VBI plans to add an additional study arm to Part B of the company’s ongoing, multi-center, open-label Phase 1/2a clinical study targeting recurrent 
&#nl
The post VBI Vaccines announces phase 2a trial of VBI-1901 plus AS01B adjuvant system in recurrent glioblastoma appeared first on Pharmaceutical Business review.
&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "30"
  ["rss_id"]=>
  string(2) "30"
  [14]=>
  string(204) "https://www.pharmaceutical-business-review.com/news/vbi-vaccines-announces-phase-2a-trial-of-vbi-1901-cancer-vaccine-candidate-in-combination-with-as01b-adjuvant-system-in-recurrent-glioblastoma-patients/"
  ["blog_url"]=>
  string(204) "https://www.pharmaceutical-business-review.com/news/vbi-vaccines-announces-phase-2a-trial-of-vbi-1901-cancer-vaccine-candidate-in-combination-with-as01b-adjuvant-system-in-recurrent-glioblastoma-patients/"
  [15]=>
  string(19) "1970-01-01 07:30:00"
  ["add_date"]=>
  string(19) "1970-01-01 07:30:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-09-14 14:31:35"
  ["create_at"]=>
  string(19) "2019-09-14 14:31:35"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}